Nintedanib versus placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: TRICC-C trial—Final results from the randomized phase II trial of the AIO. This is an ASCO ...
Doppler probe exam was a dominant strategy for assessment of upper gastrointestinal bleeding in terms of both efficacy and cost, according to study results published in Clinical Gastroenterology and ...
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center In 658 patients with advanced GI cancers who underwent both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback